Metastatic Colon Cancer, Version 3.2013
Metastatic Colon Cancer, Version 3.2013
复制标题
DOI：
10.6004/jnccn.2013.0022
复制
发表时间：
2013-02-01
影响因子：
13.4
通讯作者：
Freedman-Cass, Deborah A.
中科院分区：
文献类型：
--
作者：
Benson, Al B., III;Bekaii-Saab, Tanios;Freedman-Cass, Deborah A.
NCCN结肠癌临床实践指南（NCCN指南）开始时，患者向初级保健医生或胃肠病学家进行临床陈述，并讨论诊断、病理分期、手术管理、围手术期治疗、患者监测、复发和转移性疾病管理以及生存率。NCCN结肠癌专家组每年举行一次会议，审查其机构内审查人员的意见，并重新评估和更新他们的建议。此外，该小组还在需要新数据时召开临时会议。这些NCCN指南见解总结了NCCN结肠癌小组围绕转移性结直肠癌的讨论，用于2013年指南更新。重要的是，对晚期或转移性疾病患者的连续护理进行了改变，包括新药和额外的治疗线。（JNCCN 2013;11：141-152）
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy. (JNCCN 2013;11:141-152)